Cerclage for the Reduction of Extreme Preterm Birth in Twin Pregnancies With a Short Cervix or Dilatation

Last updated: November 9, 2023
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Overall Status: Active - Recruiting

Phase

N/A

Condition

Miscarriage

Treatment

Vaginal cerclage

Clinical Study ID

NCT05968794
TwinC
  • Ages > 16
  • Female
  • Accepts Healthy Volunteers

Study Summary

The goal of this clinical trial is to assess the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth < 28 weeks of gestational age.

The main question it aims to answer is: What is the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth < 28 weeks of gestational age?

Participants will be randomly assigned to the intervention (cerclage) or comparison (no cerclage) group.

Eligibility Criteria

Inclusion

Inclusion Criteria: Women (> 16 years of age) with a twin pregnancy and:

  • an asymptomatic short cervix at routine ultrasound investigation (below 24 weeks ofgestation) OR
  • cervical dilatation (below 24 weeks of gestation)

Exclusion

Exclusion Criteria:

  • Women with a mono-amniotic twin pregnancy
  • Women with twin pregnancy in which one or both children are diagnosed with a majorstructural, congenital or chromosomal abnormality that is likely to influence thecomposite adverse neonatal outcome.
  • Women with dilatation of the cervix and signs of clinical intra-uterine infection,defined by the presence of fever ≥ 38 degrees Celsius.
  • Women with overt symptoms of preterm labour at time of measurement of short cervix (regular contractions, PPROM, recurrent blood loss).
  • Women with a placenta previa, defined as a placenta position covering the internalostium of the cervix.
  • Women who do not master the Dutch of English language and therefore not able to givewritten consent

Study Design

Total Participants: 238
Treatment Group(s): 1
Primary Treatment: Vaginal cerclage
Phase:
Study Start date:
May 15, 2023
Estimated Completion Date:
December 01, 2028

Study Description

Rationale: In the Netherlands, 250 women with a twin pregnancy deliver at < 28 weeks per year, resulting in 157 perinatal deaths. A vaginal cerclage could be an effective surgical method to reduce cervical insufficiency and with that preterm birth, but the evidence regarding its effectiveness on extreme preterm birth and (long term) neonatal outcome is lacking.

Objective: To assess the effectiveness of a cerclage in women with a twin pregnancy with a midpregnancy short cervix or cervical dilatation compared to standard treatment (no cerclage) in the prevention of extreme preterm birth < 28 weeks of gestational age.

Nature and extent of the burden and risks associated with participation, benefit and group relatedness: A vaginal cerclage is a minor and safe surgical procedure commonly performed in singleton pregnancies with a short cervix and a previous preterm birth in all the participating centers, thus there is experience in the participating hospitals. The results of this study will show whether a vaginal cerclage reduces extreme preterm birth in women with twin pregnancy and a short cervix, and its accompanying perinatal complications. If proven effective, the implementation of this intervention will have a huge impact on the lifelong health of these children and their families.

Connect with a study center

  • University Medical Center Antwerpen

    Antwerpen,
    Belgium

    Site Not Available

  • University Medical Center Sint-Lucas Brugge

    Brugge,
    Belgium

    Site Not Available

  • Hospital Oost-Limburg Genk

    Genk,
    Belgium

    Site Not Available

  • University Medical Center Gent

    Gent,
    Belgium

    Site Not Available

  • University Medical Center Leuven

    Leuven,
    Belgium

    Site Not Available

  • University Medical Center Amsterdam

    Amsterdam,
    Netherlands

    Active - Recruiting

  • University Medical Center Groningen

    Groningen,
    Netherlands

    Site Not Available

  • University Medical Center Leiden

    Leiden,
    Netherlands

    Site Not Available

  • University Medical Center Maastricht

    Maastricht,
    Netherlands

    Site Not Available

  • Radboud University Medical Center

    Nijmegen,
    Netherlands

    Site Not Available

  • Erasmus Medical Centre

    Rotterdam,
    Netherlands

    Site Not Available

  • University Medical Center Utrecht

    Utrecht,
    Netherlands

    Site Not Available

  • Maxima Medical Centre

    Veldhoven,
    Netherlands

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.